Displaying items 37-48 of 605
» View wsbt.com items only
< Previous
1
2
3
4
5
6
7
8
9
10
11-51
Next >
-
Glaxo anti-cancer cocktail gets regulatory approval
The Baltimore SunAfter her melanoma, Cheryl Stratos is mostly back to a normal life, running a business and driving her teenage son to weekend events, but there are reminders that it could all come back: The sores all over her body, the high fevers, the hair loss --...Tags: Medical Specialization, GlaxoSmithKline PLC, McCormick Place, Health Organizations, Human Genome Sciences Inc.
-
Merck KGaA's Erbitux beats Avastin in bowel cancer trial
ReutersFRANKFURT, June 1 (Reuters) - Merck KGaA's cancer drug Erbitux was shown to be more effective at prolonging the lives of bowel cancer patients than Roche's Avastin, Merck said. In a drug trial, the two drugs were each given in combination with Folfiri...Tags: Science and Technology, Drugs and Medicines, Lilly Eli & Co, Germany, Health Treatments
-
RPT-PREVIEW-Immunotherapy is not just for melanoma anymore
Reuters(Repeats for wider distribution. No changes to headline or text) By Julie Steenhuysen and Deena Beasley CHICAGO/LOS ANGELES, May 31 (Reuters) - Diagnosed with advanced lung cancer over a year ago, Gabe Tartaglia was loath to undergo the kind of harsh...Tags: Health Treatments, Bevacizumab (drug), Cancer, Biotechnology, Chemotherapy
-
Outlook changing for PSA screening
For nearly a quarter-century, doctors have ordered annual PSA tests for men of a certain age to screen for prostate cancer, despite a lack of evidence that its benefits outweigh the risks — especially when tiny, slow-growing tumors were detected....
Tags: Death, Erectile Dysfunction, General Practitioners, Prostate Cancer, Symptoms
-
Decoding Angelina Jolie's double mastectomy and BRCA genes
Los Angeles TimesAngelina Jolie’s revelation that she underwent a preventative double mastectomy may seem like a shocking move to some. But for many women who have dangerous hereditary risks coded into their genes, this kind of surgery before cancer strikes serves...Tags: Ovarian Cancer, Breast Cancer, Tamoxifen (drug), Mastectomy, Angelina Jolie
-
Voice of the People, May. 27
Jolie's decision Angelina Jolie's decision to undergo testing for mutations in the BRCA1 and BRCA2 genes and then to undergo a double mastectomy to reduce her risk for breast and ovarian cancer was prompted by her family history. The Society of...Tags: Ovarian Cancer, Breast Cancer, Prosecution, Social Issues, Planned Parenthood
-
Double Mastectomy: Choosing A Full Life
The Hartford CourantI was moved by Angelina Jolie's recent revelation that she had a double mastectomy because she has a BRAC gene mutation that indicates a higher risk of getting breast or ovarian cancer. I am BRCA 1 positive and had my breasts removed to reduce my risk...Tags: Medical Specialization, Ovarian Cancer, Breast Cancer, Nursing, Mastectomy
-
Patient is out of network, out of luck
A worrisome abdominal pain drove Jalal Afshar to seek treatment last year at healthcare giant Kaiser Permanente. The Pasadena resident and Kaiser member had lived for years with a rare condition known as Castleman's disease, which affects the lymph...
Tags: Science and Technology, Abdominal Pain, Health Treatments, Biotechnology, Chemotherapy
-
Another 3 deals price in US high-yield; Legacy Reserves on tap
ReutersBy Joy Ferguson NEW YORK, May 22 (IFR) - Underwriters cleared out another three deals this afternoon for a total of USD1.34bn, while another USD250m bond from Legacy Reserves remained on deck. Bankers said this week that deals haven't been as over-...Tags: Petroleum Industry, Radiation Therapy, Mortgages, Banking, Health Treatments
-
Star's preventive surgery sparks breast cancer debate
Angelina Jolie's announcement Tuesday that a genetic predisposition to breast and ovarian cancer led her to undergo a preventive double mastectomy has raised both awareness about the procedure and concerns among physicians and other experts. The actress...
Tags: Ovarian Cancer, Breast Cancer, Angelina Jolie, The New York Times, Collagen Injections
-
Immune system cancer drugs tipped to be a $35 bln market
Reuters* Potential sales of $35 bln a year over next 10 years - Citigroup * Immunotherapy may be used in up to 60 percent of cancers * Bristol-Myers Squibb and Roche both upgraded to "buy" By Ben Hirschler LONDON, May 22 (Reuters) - A new wave of medicines...Tags: GlaxoSmithKline PLC, AstraZeneca Plc, Science and Technology, HIV, Drugs and Medicines
-
Elizabeth Vega Casey: Women with breast cancer gene have treatment choices
The Morning Call may not be The New York Times, but I have to acknowledge that I am not Angelina Jolie either. But there are similarities. Let me explain. Firstly, I want to take a moment to sincerely applaud her decision to reveal through The New York...Tags: Lehigh Valley Hospital, Breast Cancer, Tamoxifen (drug), Medical Procedures and Tests, Mastectomy
May 30, 2013
|Story| Baltimore Sun
Jun 1, 2013
|Story| Reuters
May 31, 2013
|Story| Reuters
Jun 1, 2013
|Story| Baltimore Sun
May 14, 2013
|Story| Los Angeles Times
May 27, 2013
|Story| Chicago Tribune
May 24, 2013
|Story| Hartford Courant
May 10, 2013
|Story| Los Angeles Times
May 22, 2013
|Story| Reuters
May 14, 2013
|Story| Chicago Tribune
May 22, 2013
|Story| Reuters
May 21, 2013
|Story| Allentown Morning Call
Original site for Oncology topic gallery.